Cargando…
Advances in hPSC expansion towards therapeutic entities: A review
For use in regenerative medicine, large‐scale manufacturing of human pluripotent stem cells (hPSCs) under current good manufacturing practice (cGMPs) is required. Much progress has been made since culturing under static two‐dimensional (2D) conditions on feeders, including feeder‐free cultures, cond...
Autores principales: | Tannenbaum, Shelly E., Reubinoff, Benjamin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357360/ https://www.ncbi.nlm.nih.gov/pubmed/35638399 http://dx.doi.org/10.1111/cpr.13247 |
Ejemplares similares
-
hPSC-derived organoids: models of human development and disease
por: Frum, Tristan, et al.
Publicado: (2020) -
hPSC-derived lung organoids: Potential opportunities and challenges
por: Du, Xiaoli, et al.
Publicado: (2023) -
Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
por: Coccia, Elena, et al.
Publicado: (2021) -
Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
por: Bodbin, Sara E., et al.
Publicado: (2020) -
The endothelium, a key actor in organ development and hPSC-derived organoid vascularization
por: Vargas-Valderrama, Alejandra, et al.
Publicado: (2020)